Eton Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ETON, and what generic alternatives to ETON drugs are available?
ETON has three approved drugs.
There are three US patents protecting ETON drugs.
There are forty-six patent family members on ETON drugs in twenty-five countries and five supplementary protection certificates in three countries.
Summary for Eton
International Patents: | 46 |
US Patents: | 3 |
Tradenames: | 3 |
Ingredients: | 3 |
NDAs: | 3 |
PTAB Cases with Eton as petitioner: | See PTAB cases with Eton as petitioner |
Drugs and US Patents for Eton
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eton | NITISINONE | nitisinone | CAPSULE;ORAL | 216201-001 | May 25, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-003 | Sep 29, 2020 | RX | Yes | No | 9,717,740 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-003 | Sep 29, 2020 | RX | Yes | No | 9,675,559 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-004 | Sep 29, 2020 | RX | Yes | Yes | 9,717,740 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eton Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Portugal | 2780003 | ⤷ Try a Trial |
Spain | 2782503 | ⤷ Try a Trial |
Mexico | 2015015759 | ⤷ Try a Trial |
United Kingdom | 201119985 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eton Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
0591275 | C300198 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: NITISINONE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZOUT; REGISTRATION NO/DATE: EU/1/04/303/001-003 20050201 |
0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
0591275 | 05C0024 | France | ⤷ Try a Trial | PRODUCT NAME: NITISINONE; REGISTRATION NO/DATE: EU/1/04/303/001 20050221 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.